Safety of Using NaviFUS System in Patients With Drug Resistant Epilepsy

Status Completed

Clinical Trial Summary

This study is to evaluate the safety and the intracranial electroencephalography (iEEG) changes of using NaviFUS System for the treatment of patients with drug resistant epilepsy.

Clinical Trial Description

This is a phase I, two-stage, prospective, open label, single center, and single-arm study. Eligible patients will be enrolled through the process of informed consent then will receive NaviFUS treatment one cycle. The time interval for each treatment cycle is 3 days, including baseline/treatment and 3 days observation. The site of the NaviFUS exposure is where the future surgery will be removed. Concomitantly use of anti-epileptic drugs (AEDs) will be monitored and recorded in the case report form (CRF). A total of six patients will be divided into two stages of recruitment, the first stage will recruit two patients, the second stage will be four patients. When the first stage is accomplished, the data and safety monitoring board (DSMB) will review the study data and provide the recommendations regarding continuation, termination, or other modifications of the study based on evaluation of observed adverse effects of the intervention. The second stage will begin to conduct after the DSMB agrees to proceed. In this clinical trial, stereo-electroencephalography (SEEG) exploration will be carried out during long-term video-EEG monitoring and excitability/irritability in focal epileptogenic region and epileptogenic network will be analyzed. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03860298
Study type	Interventional
Source	NaviFUS Corporation
Contact
Status	Completed
Phase	N/A
Start date	June 17, 2019
Completion date	October 14, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04378075` - A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy	Phase 2/Phase 3
Recruiting	`NCT05928598` - Goals for Epilepsy Clinic Visits Trial	N/A
Recruiting	`NCT05539287` - Clinical Study Evaluating the Safety of Lactobacillus Probiotic in Children With Drug Resistant Epilepsy	Phase 2
Not yet recruiting	`NCT04601974` - Lentiviral Gene Therapy for Epilepsy	Phase 1/Phase 2
Completed	`NCT02982824` - Effect of Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy	N/A
Recruiting	`NCT05485558` - the Safety and Efficacy of N-acetyl Cysteine in Children With Drug-Resistant Epilepsy	Phase 2
Not yet recruiting	`NCT04553354` - Cortical Resections in Drug Resistant Epilepsy
Recruiting	`NCT04999046` - NaviFUS™ System Neuromodulating Treatment for Patients With Drug Resistant Epilepsy	N/A
Recruiting	`NCT04714996` - Efficacy, Safety and Pharmacokinetics of ES-481 in Adult Patients With Drug Resistant Epilepsy	Phase 2
Recruiting	`NCT04839601` - RNS System RESPONSE Study	N/A
Recruiting	`NCT06059157` - Epileptogenic Network Visualisation With Advanced MRI	N/A
Recruiting	`NCT05947656` - Evaluation of the NaviFUS System in Drug Resistant Epilepsy	N/A
Recruiting	`NCT05393518` - Electroclinical Correlation of Anxiety	N/A
Not yet recruiting	`NCT05555537` - MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy
Completed	`NCT03419000` - Circulating microRNAs as Biomarkers of RESPIratory Dysfunction in Patients With Refractory epilePSY	N/A
Enrolling by invitation	`NCT06341075` - Real-World Study of Magnetic Resonance-guided Laser Interstitial Thermal Therapy for Drug-resistant Epilepsy	N/A
Not yet recruiting	`NCT05527093` - Cartography of Social Cognition Network and Their Alterations in Patients With Epilepsy	N/A
Recruiting	`NCT05697614` - The Benefit and Safety of Older Generation Anti-Epileptic Drugs (AEDs) in Drug-Resistant Epilepsy Children	Phase 4
Recruiting	`NCT06309251` - Effectiveness and Impact on the Quality of Life of Ketogenic Diet in Pediatric Patients
Recruiting	`NCT06432907` - StereoEEG Motor Neuronal Potentials Decoding	N/A